Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment
Name:
36639528.pdf
Size:
187.7Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Evans, D. G.Phillips, K. A.
Milne, R. L.
Fruscio, R.
Cybulski, C.
Gronwald, J.
Lubinski, J.
Huzarski, T.
Hyder, Z.
Forde, C.
Metcalfe, K.
Senter, L.
Weitzel, J.
Tung, N.
Zakalik, D.
Ekholm, Maria
Sun, P.
Narod, S. A.
Affiliation
Genomic Medicine, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UKIssue Date
2023
Metadata
Show full item recordCitation
Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, et al. Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment. British journal of cancer. 2023 Jan 13. PubMed PMID: 36639528. Epub 2023/01/14. eng.Journal
British Journal of CancerDOI
10.1038/s41416-022-02130-9PubMed ID
36639528Additional Links
https://dx.doi.org/10.1038/s41416-022-02130-9Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41416-022-02130-9
Scopus Count
Collections
Related articles
- Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
- Authors: Eleje GU, Eke AC, Ezebialu IU, Ikechebelu JI, Ugwu EO, Okonkwo OO
- Issue date: 2018 Aug 24
- Oestrogen receptor status and survival in women with BRCA2-associated breast cancer.
- Authors: Metcalfe K, Lynch HT, Foulkes WD, Tung N, Olopade OI, Eisen A, Lerner-Ellis J, Snyder C, Kim SJ, Sun P, Narod SA
- Issue date: 2019 Feb
- Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
- Authors: Metcalfe K, Lynch HT, Foulkes WD, Tung N, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, Sun P, Narod SA
- Issue date: 2015 Jun
- Tumour diploidy and survival in breast cancer patients with BRCA2 mutations.
- Authors: Tryggvadottir L, Olafsdottir EJ, Olafsdottir GH, Sigurdsson H, Johannsson OT, Bjorgvinsson E, Alexiusdottir K, Stefansson OA, Agnarsson BA, Narod SA, Eyfjord JE, Jonasson JG
- Issue date: 2013 Jul
- Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality.
- Authors: Evans DG, Harkness EF, Howell A, Wilson M, Hurley E, Holmen MM, Tharmaratnam KU, Hagen AI, Lim Y, Maxwell AJ, Moller P
- Issue date: 2016